Company Filing History:
2 out of 5 
2 out of 54 
1 out of 33 
Years Active: 2019-2020
Title: The Innovations of Mario Campone
Introduction
Mario Campone is a notable inventor based in Nantes, France. He has made significant contributions to the field of breast cancer management through his innovative patents. With a total of 2 patents, his work focuses on improving the diagnosis and prognosis of triple-negative breast cancer.
Latest Patents
One of his latest patents is a method for in vitro diagnosing and prognosing the recurrence of triple-negative breast cancer. This invention is particularly important as it identifies specific biomarkers that are abnormally expressed in patients suffering from this aggressive form of cancer. These biomarkers are closely related to the disease's aggressiveness and the survival rates of affected patients. Another significant patent involves olfactomedin-4, neudesin, and desmoplakin as biomarkers of breast cancer. This invention highlights the abnormal expression of these biomarkers in the blood of breast cancer patients, further aiding in the diagnosis of the disease.
Career Highlights
Mario Campone has worked with esteemed organizations such as the Institut de Cancérologie de l'Ouest and the Université d'Angers. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of his notable coworkers include Catherine Guette and Olivier Coqueret. Their collaborative efforts have contributed to the advancements in cancer diagnostics and treatment.
Conclusion
Mario Campone's innovative work in breast cancer management showcases his dedication to improving patient outcomes through advanced diagnostic methods. His contributions are vital in the ongoing fight against cancer, and his patents reflect a commitment to scientific progress.